Hello,
This may help:
In accordance with 21 CFR Sec. 10.65(e), the authority to record meetings resides with the agency staff, not the outside party. CDRH and CBER policy is not to allow outside parties to record (by audio or video) meetings with staff in order to prevent interference with the free exchange of information.
Many FDA guidance documents also state the policy against recording meetings
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM590547.pdf
- MEETING CONDUCT
Meetings will be chaired by an FDA staff member and begin with introductions and an overview
of the agenda. FDA policy prohibits audio or visual recording of discussions at meetings..
------------------------------
Lynne Witkowski RAC
Manager, Regulatory Affairs
CareFusion ( is now part of BD)
Vernon Hills IL
United States
------------------------------
Original Message:
Sent: 17-Apr-2018 12:58
From: Anonymous Member
Subject: Audio recording of FDA teleconferences.
This message was posted by a user wishing to remain anonymous
Is there any policy on recording a TC with FDA (CDRH or CBER) for any type meeting (A, B, C)? Does the sponsor have to inform all participants that the conversation is being recorded? This is only to allow additional review after the call and not to establish any binding agreement? Any guidance would be helpful.